PWA
ANRO icon

Physician Wealth Advisors’s Alto Neuroscience ANRO Stock Holding History

Physician Wealth Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-377
Closed -$815 – 2003
2025
Q1 		$815 Buy
+377
New +$1.35K ﹤0.01% 1224

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Physician Wealth Advisors's ANRO Position: Q2 2025 in Review

Physician Wealth Advisors sold out of Alto Neuroscience (ANRO) in Q2 2025, closing a stake of 377 shares — an estimated $815 sold.

Physician Wealth Advisors first reported a position in ANRO in Q1 2025 and held it in 1 quarter. The position peaked at $815 in Q1 2025. 80 funds tracked by Wall St. Rank hold ANRO as of Q2 2025.

  • Physician Wealth Advisors reported no remaining Alto Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Physician Wealth Advisors sold 377 Alto Neuroscience shares in Q2 2025, an estimated $815.
  • Physician Wealth Advisors first reported a position in Alto Neuroscience in Q1 2025 and held it in 1 quarter.
  • Physician Wealth Advisors's Alto Neuroscience position peaked at $815 in Q1 2025.
  • 80 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2025.

Based on Physician Wealth Advisors's 13F filing for Q2 2025, filed 14 Jul 2025.